Clinical Trials Logo

Ischemia clinical trials

View clinical trials related to Ischemia.

Filter by:

NCT ID: NCT06098066 Completed - Ischemic Stroke Clinical Trials

Decoding Risks and Rewards in Ischemic Stroke Surgery

Start date: May 1, 2020
Phase:
Study type: Observational

In the high-stakes battle against ischemic cerebrovascular disease, where every second counts and the margin for error is slim, how do the investigators tip the scales in favor of patient survival and improved outcomes? This groundbreaking study, the first nationwide, population-based analysis with long-term follow-up in an Asian context, dives deep into this critical question. Leveraging an expansive dataset from Taiwan's National Health Insurance Research Database, the investigators scrutinize the efficacy and risks of aggressive surgical interventions-specifically, EC-IC bypass, CEA, and CAS-in a cohort of over 84,000 patients. This paper serves as a milestone, bridging the gap between medical idealism and clinical reality. It calls for a surgical renaissance, emphasizing the need for refining techniques and enhancing patient selection protocols. If participants're looking for a comprehensive, nuanced, and, above all, actionable insight into the surgical treatment of ischemic cerebrovascular disease, this is the study that could redefine the paradigm.

NCT ID: NCT06058884 Completed - Ischemic Stroke Clinical Trials

Predictors of AIS Unfavorable Outcomes

Start date: January 3, 2022
Phase: Phase 4
Study type: Interventional

The investigators evaluated whether the characteristics of ischemic stroke patients, door-to-needle time, and stroke risk factors were predictive variables for unfavourable outcomes.

NCT ID: NCT06058507 Completed - Stroke Clinical Trials

"Carotid Web Incidence and Radiological Classification, Determination of Its Relationship With Ischemic Stroke"

Start date: April 19, 2022
Phase:
Study type: Observational

In our research, we aim to increase awareness on this issue by classifying the frequency of carotid webs and their radiological classification; Evaluating the clinical data and vascular risk factors of carotid web cases and determining their relationship with ischemic stroke and determining the measures that can be taken for future optimal treatment. We aimed to contribute to their approach.

NCT ID: NCT06056687 Completed - Diabetes Mellitus Clinical Trials

Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of alpha-lipoic acid on inflammatory markers and cardiac fibrosis markers in diabetic patients with Ischemic Cardiomyopathy.

NCT ID: NCT06031350 Completed - Clinical trials for Non-arteritic Ischemic Optic Neuropathy

Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study

Start date: June 1, 2021
Phase:
Study type: Observational [Patient Registry]

This series aims at studying the peripapillary and macular vascular changes in subjects with unilateral anterior ischemic optic neuropathy via Optical Coherence Tomography Angiography (OCTA).

NCT ID: NCT06022588 Completed - Clinical trials for Chronic Mesenteric Ischemia

Chronic Mesenteric Ischemia Breath Testing

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Background and aims: A gold standard diagnostic test to diagnose chronic mesenteric ischemia is currently lacking. Isotope labelled-butyrate and glucose breath testing could theoretically quantify mucosal oxygen consumption and thereby detect ischemia, since oxygen is needed to absorb and metabolize butyrate and glucose, and distinguish aerobic/anaerobic intestinal epithelial metabolism. Here we aim to test this notion and compare results to conventional biomarkers. Methods: Healthy volunteers were randomized into two control groups and two intervention groups, each consisting of five volunteers receiving either oral 13C -butyrate or 13C -glucose. The control groups performed breath tests without any physical exercise. The intervention groups performed a 30 minutes standardized bicycle exercise test, which has been proven to elicit mesenteric ischemia. Breath samples of expired 13CO2 were collected during a period of 4 hours and results were contrasted to measurements of biomarkers in peripheral blood.

NCT ID: NCT06005636 Completed - Ischemic Stroke Clinical Trials

Post-stroke Delirium in Ischemic Stroke Patients

Start date: September 1, 2021
Phase:
Study type: Observational

This study is to investigate the predictors of post-stroke delirium, develop and validate a nomogram of post-stroke delirium in the ischemic stroke patients.

NCT ID: NCT05996978 Completed - Ischemic Stroke Clinical Trials

Intensive Drug Therapy for Ischemic Stroke Caused by Severe Intracranial Arterial Stenosis

Start date: February 1, 2020
Phase:
Study type: Observational

To observe the safety and efficacy of intensive drug therapy for ischemic stroke caused by severe intracranial arterial stenosis.Patients with acute stroke caused by intracranial arterial stenosis (stenosis rate ≥70%) were enrolled and accept dual antiplatelet therapy (DAPT) (aspirin 100 mg/d and clopidogrel 75 mg/d for 90 days, followed by aspirin 100 mg/d for long term) under the guidance of platelet function analysis (Verifynow) combined with the intensive statin therapy (40 mg/d for 14 days, followed by 20 mg/d for long term).

NCT ID: NCT05882123 Completed - Clinical trials for Acute Ischemic Stroke

Gender Heterogeneity in the Influencing Factors for Cerebral Microbleeds in Acute Ischemic Stroke Patients

Start date: January 2014
Phase:
Study type: Observational

The investigators continuously collected data from 482 AIS inpatients at the Neurology Department of Hebei General Hospital. Both demographic and clinical data were collected from the study subjects. Different head magnetic resonance imaging sequences were used to assess the subjects' CMBs, white matter lesions, and old lacunar infarcts (LI). Various statistical methods, including the t-test, χ2 test, and logistic regression, were used to analyze the gender heterogeneity of the influencing factors for CMBs in AIS patients.

NCT ID: NCT05868538 Completed - Clinical trials for Behçet's Diseasecases

Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease

Start date: April 1, 2019
Phase:
Study type: Observational

Behçet's Disease activity was evaluated using BD Current Activity Form (BDCAF). Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.